Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Slamon, Dennis"'
Autor:
McDermott MSJ; Department of Medicine, Division of Hematology/Oncology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California., O'Brien NA; Department of Medicine, Division of Hematology/Oncology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California., Hoffstrom B; Department of Medicine, Division of Hematology/Oncology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California., Gong K; Department of Medicine, Division of Hematology/Oncology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California., Lu M; Department of Medicine, Division of Hematology/Oncology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California., Zhang J; Department of Medicine, Division of Hematology/Oncology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California., Luo T; Department of Medicine, Division of Hematology/Oncology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California., Liang M; Department of Medicine, Division of Hematology/Oncology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California., Jia W; Department of Medicine, Division of Hematology/Oncology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California., Hong JJ; Department of Medicine, Division of Hematology/Oncology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California., Chau K; Department of Medicine, Division of Hematology/Oncology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California., Davenport S; Pathology, University of Southern California, Los Angeles, California., Xie B; Pathology, University of Southern California, Los Angeles, California., Press MF; Pathology, University of Southern California, Los Angeles, California., Panayiotou R; Department of Cell Biology and Ludwig Center at Harvard, Harvard Medical School, Boston, Massachusetts., Handly-Santana A; Department of Cell Biology and Ludwig Center at Harvard, Harvard Medical School, Boston, Massachusetts., Brugge JS; Department of Cell Biology and Ludwig Center at Harvard, Harvard Medical School, Boston, Massachusetts., Presta L; Department of Medicine, Division of Hematology/Oncology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California., Glaspy J; Department of Medicine, Division of Hematology/Oncology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California., Slamon DJ; Department of Medicine, Division of Hematology/Oncology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2023 Jun 01; Vol. 29 (11), pp. 2131-2143.
Autor:
Wainberg ZA; David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California., Singh AS; David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California., Konecny GE; David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California., McCann KE; David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California., Hecht JR; David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California., Goldman J; David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California., Chmielowski B; David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California., Finn RS; David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California., O'Brien N; David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California., Von Euw E; David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California., Price MM; David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California., Martinez D; David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California., Yonemoto L; David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California., Brennan M; David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California., Glaspy JA; David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California., Slamon DJ; David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2023 Jan 04; Vol. 29 (1), pp. 40-49.
Autor:
Cristofanilli M; Weill Cornell Medicine, New York, New York., Rugo HS; University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, California., Im SA; Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of South Korea., Slamon DJ; David Geffen School of Medicine at University of California Los Angeles, Santa Monica, California., Harbeck N; Brustzentrum, Frauenklinik and CCC Munich, LMU University Hospital, Munich, Germany., Bondarenko I; Dnipropetrovsk Medical Academy, City Multiple-Discipline Clinical Hospital #4, Dnipropetrovsk, Ukraine., Masuda N; Nagoya University Graduate School of Medicine, Showa-ku, Nagoya, Japan., Colleoni M; IEO, Istituto Europeo di Oncologia, IRCCS, Milan, Italy., DeMichele A; Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania., Loi S; Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia., Iwata H; Aichi Cancer Center Hospital, Chikusa-ku, Nagoya, Japan., O'Leary B; Royal Marsden Hospital and Institute of Cancer Research, London, United Kingdom., André F; Institut Gustave Roussy, Villejuif, France., Loibl S; German Breast Group, Neu-Isenburg, Germany., Bananis E; Pfizer Inc, New York, New York., Liu Y; Pfizer Inc, San Diego, California., Huang X; Pfizer Inc, San Diego, California., Kim S; Pfizer Inc, San Diego, California., Lechuga Frean MJ; Pfizer Inc, San Diego, California., Turner NC; Royal Marsden Hospital and Institute of Cancer Research, London, United Kingdom.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2022 Aug 15; Vol. 28 (16), pp. 3433-3442.
Autor:
Peddi PF; Saint John's Cancer Institute, Santa Monica, California., Fasching PA; Department of Gynecology and Obstetrics, Erlangen University Hospital, Erlangen, Germany., Liu D; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota., Quinaux E; Biostatistics, International Drug Development Institute, Ottignies-Louvain-la-Neuve, Belgium., Robert NJ; Virginia Cancer Specialists, Fairfax, Virginia., Valero V; Department of Breast Medical Oncology, MD Anderson Cancer Center, Houston, Texas., Crown J; Medical Oncology, St. Vincent's University Hospital, Dublin, Ireland., Falkson C; Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, New York., Brufsky A; Department of Hematology and Oncology, University of Pittsburgh, Pittsburgh, Pennsylvania., Cunningham JM; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota., Weinshilboum RM; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota., Pienkowski T; Maria Sklodowska-Curie Center, Warszawa, Poland., Eiermann W; Department of Gynecology, IOZ München, Bavaria, Germany., Martín M; Medical Oncology, Department of Medical Oncology, Hospital General Universitario Gregorio Marañón, Madrid, Spain., Bee V; Project Management, Translational Oncology Research International, Los Angeles, California., Wang X; Department of General Internal Medicine and Health Services Research, University of California Los Angeles, California., Wang L; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota., Yang E; Department of General Internal Medicine and Health Services Research, University of California Los Angeles, California., Slamon DJ; Department of General Internal Medicine and Health Services Research, University of California Los Angeles, California., Hurvitz SA; Department of General Internal Medicine and Health Services Research, University of California Los Angeles, California.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2022 May 02; Vol. 28 (9), pp. 1854-1862.
Autor:
García-Sáenz JÁ; Medical Oncology, Hospital Clínico Universitario San Carlos, Madrid, Spain.; Centro de Investigación Biomédica en Red CIBERONC-ISCIII, Madrid, Spain.; GEICAM Spanish Breast Cancer Group, Madrid, Spain., Martínez-Jáñez N; GEICAM Spanish Breast Cancer Group, Madrid, Spain.; Medical Oncology, Hospital Universitario Ramón y Cajal, Madrid, Spain., Cubedo R; GEICAM Spanish Breast Cancer Group, Madrid, Spain.; Medical Oncology, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain., Jerez Y; Centro de Investigación Biomédica en Red CIBERONC-ISCIII, Madrid, Spain.; GEICAM Spanish Breast Cancer Group, Madrid, Spain.; Medical Oncology, Hospital General Universitario Gregorio Marañón, Madrid, Spain.; Fundación de Investigación Biomédica, Hospital General Universitario Gregorio Marañón, Madrid, Spain.; Universidad Complutense de Madrid, Madrid, Spain., Lahuerta A; GEICAM Spanish Breast Cancer Group, Madrid, Spain.; Medical Oncology, Onkologikoa, Gipuzkoa, Spain., González-Santiago S; GEICAM Spanish Breast Cancer Group, Madrid, Spain.; Medical Oncology, Hospital Universitario San Pedro de Alcántara, Cáceres, Spain., Ferrer N; GEICAM Spanish Breast Cancer Group, Madrid, Spain.; Medical Oncology, Hospital Universitari Son Espases, Palma, Spain., Ramos M; GEICAM Spanish Breast Cancer Group, Madrid, Spain.; Medical Oncology, Centro Oncológico de Galicia, A Coruña, Spain., Alonso-Romero JL; GEICAM Spanish Breast Cancer Group, Madrid, Spain.; Medical Oncology, Hospital Clínico Universitario Virgen de la Arrixaca, IMIB-Arrixaca, Murcia, Spain., Antón A; GEICAM Spanish Breast Cancer Group, Madrid, Spain.; Medical Oncology, Hospital Universitario Miguel Servet, Zaragoza, Spain., Carrasco E; GEICAM Spanish Breast Cancer Group, Madrid, Spain., Chen J; Takeda Development Center Americas, Inc. (TDCA), Lexington, Massachusetts., Neuwirth R; Takeda Development Center Americas, Inc. (TDCA), Lexington, Massachusetts., Galinsky K; Takeda Development Center Americas, Inc. (TDCA), Lexington, Massachusetts., Vincent S; Takeda Development Center Americas, Inc. (TDCA), Lexington, Massachusetts., Leonard EJ; Takeda Development Center Americas, Inc. (TDCA), Lexington, Massachusetts., Slamon D; Division of Hematology/Oncology, Department of Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2022 Mar 15; Vol. 28 (6), pp. 1107-1116.
Autor:
De Angelis C, Fu X, Cataldo ML, Nardone A, Pereira R, Veeraraghavan J, Nanda S, Qin L, Sethunath V, Wang T, Hilsenbeck SG, Benelli M, Migliaccio I, Guarducci C, Malorni L, Litchfield LM, Liu J, Donaldson J, Selenica P, Brown DN, Weigelt B, Reis-Filho JS, Park BH, Hurvitz SA, Slamon DJ, Rimawi MF, Jansen VM, Jeselsohn R, Osborne CK, Schiff R
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2021 Sep 01; Vol. 27 (17), pp. 4939.
Autor:
De Angelis C; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.; Department of Medicine, Baylor College of Medicine, Houston, Texas.; Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas.; Department of Clinical Medicine and Surgery, University of Naples 'Federico II', Naples, Italy., Fu X; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.; Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas.; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas., Cataldo ML; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.; Department of Medicine, Baylor College of Medicine, Houston, Texas.; Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas.; Department of Clinical Medicine and Surgery, University of Naples 'Federico II', Naples, Italy., Nardone A; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Pereira R; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.; Department of Medicine, Baylor College of Medicine, Houston, Texas.; Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas., Veeraraghavan J; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.; Department of Medicine, Baylor College of Medicine, Houston, Texas.; Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas., Nanda S; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.; Department of Medicine, Baylor College of Medicine, Houston, Texas.; Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas., Qin L; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.; Department of Medicine, Baylor College of Medicine, Houston, Texas.; Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas., Sethunath V; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.; Department of Medicine, Baylor College of Medicine, Houston, Texas.; Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas., Wang T; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.; Department of Medicine, Baylor College of Medicine, Houston, Texas.; Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas., Hilsenbeck SG; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.; Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas., Benelli M; 'Sandro Pitigliani' Translational Research Unit, Hospital of Prato, Prato, Italy., Migliaccio I; 'Sandro Pitigliani' Translational Research Unit, Hospital of Prato, Prato, Italy.; 'Sandro Pitigliani' Medical Oncology Department, Hospital of Prato, Prato, Italy., Guarducci C; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; 'Sandro Pitigliani' Translational Research Unit, Hospital of Prato, Prato, Italy., Malorni L; 'Sandro Pitigliani' Translational Research Unit, Hospital of Prato, Prato, Italy.; 'Sandro Pitigliani' Medical Oncology Department, Hospital of Prato, Prato, Italy., Litchfield LM; Eli Lilly and Company, Indianapolis, Indiana., Liu J; Eli Lilly and Company, Indianapolis, Indiana., Donaldson J; Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee., Selenica P; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York., Brown DN; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York., Weigelt B; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York., Reis-Filho JS; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York., Park BH; Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee., Hurvitz SA; University of California, Los Angeles, Los Angeles, California., Slamon DJ; University of California, Los Angeles, Los Angeles, California., Rimawi MF; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.; Department of Medicine, Baylor College of Medicine, Houston, Texas.; Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas.; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas., Jansen VM; Eli Lilly and Company, Indianapolis, Indiana., Jeselsohn R; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Osborne CK; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.; Department of Medicine, Baylor College of Medicine, Houston, Texas.; Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas.; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas., Schiff R; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas. rschiff@bcm.edu.; Department of Medicine, Baylor College of Medicine, Houston, Texas.; Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas.; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2021 Sep 01; Vol. 27 (17), pp. 4870-4882. Date of Electronic Publication: 2021 Feb 03.
Autor:
Talhouk A; British Columbia's Gynecological Cancer Research Program (OVCARE), BC Cancer, Vancouver General Hospital, and University of British Columbia, Vancouver, British Columbia, Canada.; University of British Columbia, Department of Obstetrics and Gynecology, Vancouver, British Columbia, Canada., George J; The Jackson Laboratory for Genomic Medicine, Farmington, Connecticut., Wang C; Mayo Clinic, Division of Biomedical Statistics and Informatics, Department of Health Science Research, Rochester, Minnesota., Budden T; University of NSW Sydney, School of Women's and Children's Health, Faculty of Medicine, Sydney, New South Wales, Australia.; The University of Manchester, CRUK Manchester Institute, Manchester, United Kingdom., Tan TZ; National University of Singapore, Cancer Science Institute of Singapore, Center for Translational Medicine, Singapore, Singapore., Chiu DS; British Columbia's Gynecological Cancer Research Program (OVCARE), BC Cancer, Vancouver General Hospital, and University of British Columbia, Vancouver, British Columbia, Canada., Kommoss S; Tuebingen University Hospital, Department of Women's Health, Tuebingen, Germany., Leong HS; Peter MacCallum Cancer Center, Melbourne, Victoria, Australia., Chen S; Cedars-Sinai Medical Center, Center for Cancer Prevention and Translational Genomics, Samuel Oschin Comprehensive Cancer Institute, Los Angeles, California., Intermaggio MP; University of NSW Sydney, School of Women's and Children's Health, Faculty of Medicine, Sydney, New South Wales, Australia., Gilks B; British Columbia's Gynecological Cancer Research Program (OVCARE), BC Cancer, Vancouver General Hospital, and University of British Columbia, Vancouver, British Columbia, Canada.; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada., Nazeran TM; British Columbia's Gynecological Cancer Research Program (OVCARE), BC Cancer, Vancouver General Hospital, and University of British Columbia, Vancouver, British Columbia, Canada., Volchek M; Royal Women's Hospital, Anatomical Pathology, Parkville, Victoria, Australia., Elatre W; Department of Pathology, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, California., Bentley RC; Department of Pathology, Duke University Hospital, Durham, North Carolina., Senz J; British Columbia's Gynecological Cancer Research Program (OVCARE), BC Cancer, Vancouver General Hospital, and University of British Columbia, Vancouver, British Columbia, Canada.; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada., Lum A; British Columbia's Gynecological Cancer Research Program (OVCARE), BC Cancer, Vancouver General Hospital, and University of British Columbia, Vancouver, British Columbia, Canada., Chow V; British Columbia's Gynecological Cancer Research Program (OVCARE), BC Cancer, Vancouver General Hospital, and University of British Columbia, Vancouver, British Columbia, Canada., Sudderuddin H; British Columbia's Gynecological Cancer Research Program (OVCARE), BC Cancer, Vancouver General Hospital, and University of British Columbia, Vancouver, British Columbia, Canada., Mackenzie R; British Columbia's Gynecological Cancer Research Program (OVCARE), BC Cancer, Vancouver General Hospital, and University of British Columbia, Vancouver, British Columbia, Canada., Leong SCY; British Columbia's Gynecological Cancer Research Program (OVCARE), BC Cancer, Vancouver General Hospital, and University of British Columbia, Vancouver, British Columbia, Canada., Liu G; British Columbia's Gynecological Cancer Research Program (OVCARE), BC Cancer, Vancouver General Hospital, and University of British Columbia, Vancouver, British Columbia, Canada., Johnson D; British Columbia's Gynecological Cancer Research Program (OVCARE), BC Cancer, Vancouver General Hospital, and University of British Columbia, Vancouver, British Columbia, Canada., Chen B; British Columbia's Gynecological Cancer Research Program (OVCARE), BC Cancer, Vancouver General Hospital, and University of British Columbia, Vancouver, British Columbia, Canada., Group A; Peter MacCallum Cancer Center, Melbourne, Victoria, Australia.; QIMR Berghofer Medical Research Institute, Department of Genetics and Computational Biology, Brisbane, Queensland, Australia.; Centre for Cancer Research, The Westmead Institute for Medical Research, The University of Sydney, Sydney, New South Wales, Australia., Alsop J; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, United Kingdom., Banerjee SN; The Royal Marsden NHS Foundation Trust and Institute of Cancer Research, Gynaecology Unit, London, United Kingdom., Behrens S; German Cancer Research Center (DKFZ), Division of Cancer Epidemiology, Heidelberg, Germany., Bodelon C; NCI, Division of Cancer Epidemiology and Genetics, Bethesda, Maryland., Brand AH; Department of Gynaecological Oncology, Westmead Hospital, Sydney, New South Wales, Australia., Brinton L; NCI, Division of Cancer Epidemiology and Genetics, Bethesda, Maryland., Carney ME; Department of Obstetrics and Gynecology, University of Hawaii, John A. Burns School of Medicine, Honolulu, Hawaii., Chiew YE; Centre for Cancer Research, The Westmead Institute for Medical Research, The University of Sydney, Sydney, New South Wales, Australia.; Department of Gynaecological Oncology, Westmead Hospital, Sydney, New South Wales, Australia., Cushing-Haugen KL; Fred Hutchinson Cancer Research Center, Program in Epidemiology, Division of Public Health Sciences, Seattle, Washington., Cybulski C; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland., Ennis D; Imperial College London, Division of Cancer and Ovarian Cancer Action Research Centre, Department Surgery & Cancer, London, United Kingdom.; Institute of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom., Fereday S; Peter MacCallum Cancer Center, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia., Fortner RT; German Cancer Research Center (DKFZ), Division of Cancer Epidemiology, Heidelberg, Germany., García-Donas J; HM Hospitales Centro Integral Oncológico Clara Campal (HM CIOCC), Madrid, Spain., Gentry-Maharaj A; University College London, MRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, London, United Kingdom., Glasspool R; Department of Medical Oncology, Beatson West of Scotland Cancer Centre and University of Glasgow, Glasgow, United Kingdom., Goranova T; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom., Greene CS; Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Haluska P; Mayo Clinic, Department of Oncology, Rochester, Minnesota., Harris HR; Fred Hutchinson Cancer Research Center, Program in Epidemiology, Division of Public Health Sciences, Seattle, Washington.; Department of Epidemiology, University of Washington, Seattle, Washington., Hendley J; Peter MacCallum Cancer Center, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia., Hernandez BY; University of Hawaii Cancer Center, Cancer Epidemiology Program, Honolulu, Hawaii., Herpel E; Institute of Pathology and NCT Tissue Bank, University Hospital Heidelberg, Heidelberg, Germany., Jimenez-Linan M; Addenbrooke's Hospital NHS Trust, Department of Pathology, Cambridge, United Kingdom., Karpinskyj C; University College London, MRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, London, United Kingdom., Kaufmann SH; Mayo Clinic, Department of Oncology, Rochester, Minnesota.; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota., Keeney GL; Division of Anatomic Pathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota., Kennedy CJ; Centre for Cancer Research, The Westmead Institute for Medical Research, The University of Sydney, Sydney, New South Wales, Australia.; Department of Gynaecological Oncology, Westmead Hospital, Sydney, New South Wales, Australia., Köbel M; Department of Pathology and Laboratory Medicine, Foothills Medical Center, University of Calgary, Calgary, Alberta, Canada., Koziak JM; Alberta Health Services-Cancer Care, Calgary, Alberta, Canada., Larson MC; Mayo Clinic, Division of Biomedical Statistics and Informatics, Department of Health Science Research, Rochester, Minnesota., Lester J; David Geffen School of Medicine, Department of Obstetrics and Gynecology, University of California at Los Angeles, Los Angeles, California.; Cedars-Sinai Medical Center, Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Los Angeles, California., Lewsley LA; Cancer Research UK Clinical Trials Unit, Institute of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom., Lissowska J; M Sklodowska Curie National Research Institute of Oncology, Department of Cancer Epidemiology and Prevention, Warsaw, Poland., Lubiński J; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland., Luk H; University of Hawaii Cancer Center, Cancer Epidemiology Program, Honolulu, Hawaii., Macintyre G; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom., Mahner S; Department of Obstetrics and Gynecology, University Hospital, Ludwig Maximilian University of Munich, Munich, Germany., McNeish IA; Imperial College London, Division of Cancer and Ovarian Cancer Action Research Centre, Department Surgery & Cancer, London, United Kingdom.; Institute of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom., Menkiszak J; Department of Gynecological Surgery and Gynecological Oncology of Adults and Adolescents, Pomeranian Medical University, Szczecin, Poland., Nevins N; Department of Gynaecological Oncology, Westmead Hospital and Centre for Cancer Research, The Westmead Institute for Medical Research, The University of Sydney, Sydney, New South Wales, Australia., Osorio A; Centro de Investigación en Red de Enfermedades Raras (CIBERER), Madrid, Spain.; Spanish National Cancer Research Centre (CNIO), Human Cancer Genetics Programme, Madrid, Spain., Oszurek O; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland., Palacios J; Hospital Universitario Ramón y Cajal, Pathology Department. IRYCIS. CIBERONC. Universidad de Alcalá, Madrid, Spain., Hinsley S; Cancer Research UK Clinical Trials Unit, Institute of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom., Pearce CL; Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, Michigan.; Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California., Pike MC; Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California.; Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York., Piskorz AM; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom., Ray-Coquard I; Centre Leon Berard and University Claude Bernard Lyon 1, Lyon, France., Rhenius V; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, United Kingdom., Rodriguez-Antona C; Spanish National Cancer Research Centre (CNIO), Human Cancer Genetics Programme, Madrid, Spain.; Biomedical Network on Rare Diseases (CIBERER), Madrid, Spain., Sharma R; Pathology West ICPMR Westmead, Westmead Hospital, The University of Sydney, Sydney, New South Wales, Australia.; University of Western Sydney at Westmead Hospital, Sydney, New South Wales, Australia., Sherman ME; Department of Health Sciences Research, Mayo Clinic College of Medicine, Jacksonville, Florida., De Silva D; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom., Singh N; Department of Pathology, Barts Health National Health Service Trust, London, United Kingdom., Sinn P; Department of Pathology, Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany., Slamon D; Division of Hematology and Oncology, Department of Medicine, University of California at Los Angeles, David Geffen School of Medicine, Los Angeles, California., Song H; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, United Kingdom., Steed H; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Royal Alexandra Hospital, Edmonton, Alberta, Canada., Stronach EA; Imperial College London, Division of Cancer and Ovarian Cancer Action Research Centre, Department Surgery & Cancer, London, United Kingdom., Thompson PJ; Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute, Cancer Prevention and Genetics Program, Los Angeles, California., Tołoczko A; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland., Trabert B; NCI, Division of Cancer Epidemiology and Genetics, Bethesda, Maryland., Traficante N; Peter MacCallum Cancer Center, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia., Tseng CC; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California., Widschwendter M; Department of Women's Cancer, Institute for Women's Health, University College London, London, United Kingdom., Wilkens LR; University of Hawaii Cancer Center, Cancer Epidemiology Program, Honolulu, Hawaii., Winham SJ; Mayo Clinic, Division of Biomedical Statistics and Informatics, Department of Health Science Research, Rochester, Minnesota., Winterhoff B; Department of Obstetrics, Gynecology and Women's Health, University of Minnesota, Minneapolis, Minnesota., Beeghly-Fadiel A; Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee., Benitez J; Centro de Investigación en Red de Enfermedades Raras (CIBERER), Madrid, Spain.; Spanish National Cancer Research Centre (CNIO), Human Cancer Genetics Programme, Madrid, Spain., Berchuck A; Department of Gynecologic Oncology, Duke University Hospital, Durham, North Carolina., Brenton JD; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom., Brown R; Division of Cancer and Ovarian Cancer Action Research Centre, Department of Surgery and Cancer, Imperial College London, London, United Kingdom., Chang-Claude J; German Cancer Research Center (DKFZ), Division of Cancer Epidemiology, Heidelberg, Germany.; University Medical Center Hamburg-Eppendorf, Cancer Epidemiology Group, University Cancer Center Hamburg (UCCH), Hamburg, Germany., Chenevix-Trench G; QIMR Berghofer Medical Research Institute, Department of Genetics and Computational Biology, Brisbane, Queensland, Australia., deFazio A; Centre for Cancer Research, The Westmead Institute for Medical Research, The University of Sydney, Sydney, New South Wales, Australia.; Department of Gynaecological Oncology, Westmead Hospital, Sydney, New South Wales, Australia., Fasching PA; Division of Hematology and Oncology, Department of Medicine, University of California at Los Angeles, David Geffen School of Medicine, Los Angeles, California.; Department of Gynecology and Obstetrics, Comprehensive Cancer Center ER-EMN, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany., García MJ; Spanish National Cancer Research Centre (CNIO), Human Cancer Genetics Programme, Madrid, Spain.; Biomedical Network on Rare Diseases (CIBERER), Madrid, Spain., Gayther SA; Cedars-Sinai Medical Center, Center for Bioinformatics and Functional Genomics and the Cedars Sinai Genomics Core, Los Angeles, California., Goodman MT; Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute, Cancer Prevention and Genetics Program, Los Angeles, California., Gronwald J; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland., Henderson MJ; Children's Cancer Institute, Lowy Cancer Research Centre, University of NSW Sydney, Sydney, New South Wales, Australia., Karlan BY; David Geffen School of Medicine, Department of Obstetrics and Gynecology, University of California at Los Angeles, Los Angeles, California.; Cedars-Sinai Medical Center, Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Los Angeles, California., Kelemen LE; Hollings Cancer Center and Department of Public Health Sciences, Medical University of South Carolina, Charleston, South Carolina., Menon U; University College London, MRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, London, United Kingdom., Orsulic S; David Geffen School of Medicine, Department of Obstetrics and Gynecology, University of California at Los Angeles, Los Angeles, California.; Cedars-Sinai Medical Center, Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Los Angeles, California., Pharoah PDP; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, United Kingdom.; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom., Wentzensen N; NCI, Division of Cancer Epidemiology and Genetics, Bethesda, Maryland., Wu AH; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California., Schildkraut JM; Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia., Rossing MA; Fred Hutchinson Cancer Research Center, Program in Epidemiology, Division of Public Health Sciences, Seattle, Washington.; Department of Epidemiology, University of Washington, Seattle, Washington., Konecny GE; Division of Hematology and Oncology, Department of Medicine, University of California at Los Angeles, David Geffen School of Medicine, Los Angeles, California., Huntsman DG; British Columbia's Gynecological Cancer Research Program (OVCARE), BC Cancer, Vancouver General Hospital, and University of British Columbia, Vancouver, British Columbia, Canada.; University of British Columbia, Department of Obstetrics and Gynecology, Vancouver, British Columbia, Canada.; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.; Department of Molecular Oncology, BC Cancer Research Centre, Vancouver, British Columbia, Canada., Huang RY; National University of Singapore, Cancer Science Institute of Singapore, Center for Translational Medicine, Singapore, Singapore.; National Taiwan University, School of Medicine, College of Medicine, Taipei City, Taiwan., Goode EL; Division of Epidemiology, Department of Health Science Research, Mayo Clinic, Rochester, Minnesota. m.anglesio@ubc.ca David.bowtell@petermac.org jen.doherty@hci.utah.edu s.ramus@unsw.edu.au egoode@mayo.edu., Ramus SJ; University of NSW Sydney, School of Women's and Children's Health, Faculty of Medicine, Sydney, New South Wales, Australia. m.anglesio@ubc.ca David.bowtell@petermac.org jen.doherty@hci.utah.edu s.ramus@unsw.edu.au egoode@mayo.edu.; Adult Cancer Program, Lowy Cancer Research Centre, University of NSW Sydney, Sydney, New South Wales, Australia., Doherty JA; Department of Population Health Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah. m.anglesio@ubc.ca David.bowtell@petermac.org jen.doherty@hci.utah.edu s.ramus@unsw.edu.au egoode@mayo.edu., Bowtell DD; Peter MacCallum Cancer Center, Melbourne, Victoria, Australia. m.anglesio@ubc.ca David.bowtell@petermac.org jen.doherty@hci.utah.edu s.ramus@unsw.edu.au egoode@mayo.edu.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia., Anglesio MS; British Columbia's Gynecological Cancer Research Program (OVCARE), BC Cancer, Vancouver General Hospital, and University of British Columbia, Vancouver, British Columbia, Canada. m.anglesio@ubc.ca David.bowtell@petermac.org jen.doherty@hci.utah.edu s.ramus@unsw.edu.au egoode@mayo.edu.; University of British Columbia, Department of Obstetrics and Gynecology, Vancouver, British Columbia, Canada.; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2020 Oct 15; Vol. 26 (20), pp. 5411-5423. Date of Electronic Publication: 2020 Jun 17.
Autor:
Hurvitz SA; University of California, Los Angeles, Los Angeles, California. shurvitz@mednet.ucla.edu., Martin M; Instituto de Investigacion Sanitaria Gregorio Marañon, Ciberonc, Departamento de Medicina, Universidad Complutense, Madrid, Spain., Press MF; University of Southern California, Los Angeles, California., Chan D; Cancer Care Associates, Redondo Beach, California., Fernandez-Abad M; Hospital Universitario Ramón y Cajal, Madrid, Spain., Petru E; Medical University Graz, Graz, Austria., Rostorfer R; UF Health Cancer Center at Orlando Health, Orlando, Florida., Guarneri V; University of Padova, Istituto Oncologico Veneto IRCCS, Padova, Italy., Huang CS; National Taiwan University Hospital, Taipei, Taiwan., Barriga S; Eli Lilly and Company, Madrid, Spain., Wijayawardana S; Eli Lilly and Company, Indianapolis, Indiana., Brahmachary M; Eli Lilly and Company, New York, New York., Ebert PJ; Eli Lilly and Company, Indianapolis, Indiana., Hossain A; Eli Lilly and Company, Indianapolis, Indiana., Liu J; Eli Lilly and Company, Indianapolis, Indiana., Abel A; Eli Lilly and Company, Indianapolis, Indiana., Aggarwal A; Eli Lilly and Company, Indianapolis, Indiana., Jansen VM; Eli Lilly and Company, Indianapolis, Indiana., Slamon DJ; University of California, Los Angeles, Los Angeles, California.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2020 Feb 01; Vol. 26 (3), pp. 566-580. Date of Electronic Publication: 2019 Oct 15.
Autor:
Finn RS; Division of Hematology/Oncology, David Geffen School of Medicine at UCLA, Santa Monica, California. RFinn@mednet.ucla.edu., Liu Y; Pfizer Inc, Global Product Development Oncology, La Jolla, California., Zhu Z; Pfizer Inc, Oncology Translational Research/Computational Biology, La Jolla, California., Martin M; Instituto de Investigación Sanitaria Gregorio Marañón, Ciberonc, Universidad Complutense, Madrid, Spain., Rugo HS; Department of Medicine (Hematology/Oncology), University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, California., Diéras V; Department of Breast Oncology, Institut Curie, and Centre Eugène Marquis, Rennes, France., Im SA; Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea., Gelmon KA; Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, British Columbia, Canada., Harbeck N; Department of OB&GYN, Brustzentrum der Universität München (LMU), München, Germany., Lu DR; Pfizer Inc, Clinical Statistics, La Jolla, California., Gauthier E; Pfizer Inc, Department of Clinical Research, San Francisco, California., Huang Bartlett C; Pfizer Inc, Global Medical Affairs, Collegeville, Pennsylvania., Slamon DJ; Division of Hematology/Oncology, David Geffen School of Medicine at UCLA, Santa Monica, California.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2020 Jan 01; Vol. 26 (1), pp. 110-121. Date of Electronic Publication: 2019 Sep 16.